Publications by authors named "B Bobic"

Article Synopsis
  • - The review analyzed human cases of Hymenolepis diminuta across Europe up to July 2022, focusing on publications with demographic, clinical, or epidemiological data, including a specific case from Belgrade.
  • - A total of 104 confirmed cases were identified, with nearly half originating from Mediterranean countries; common symptoms among symptomatic children included diarrhea, abdominal pain, and behavioral changes.
  • - Diagnosis involved detecting the parasite's eggs in stool samples, and treatment with praziquantel or niclosamide was effective, while albendazole and mebendazole were not; future studies are recommended to improve understanding of this infection's distribution and character.
View Article and Find Full Text PDF

The aim of this study was to evaluate immunogenicity and longevity of the humoral immune response within six months after the homologous (BNT162b2/BNT162b2) or heterologous (BBIBP-CorV/BNT162b2) third dose, and to assess breakthrough infections among vaccinees during the Omicron wave in Serbia. Serum samples were analyzed at four timepoints: five months after the primary series; three weeks, three months, and six months after the boost. IgG antibodies against the receptor-binding domain of the spike protein were detected using enzyme-linked fluorescence assay.

View Article and Find Full Text PDF

Toxoplasmosis, caused by the cosmopolitan protozoan , has particular implications during pregnancy due to the possible transmission of infection to the fetus. Very few studies have assessed seroprevalence and the risk factors for toxoplasmosis in healthy pregnant women. The aim of this study was to examine the seroprevalence of infection in healthy pregnant women and to identify the associated risk factors for toxoplasmosis.

View Article and Find Full Text PDF
Article Synopsis
  • * Despite being a notifiable disease, it is under-reported in European health systems, prompting a systematic review of case data from 1997 to 2021.
  • * The review identified 64,745 cases in 40 European countries, with a mean annual incidence of 0.64 cases per 100,000 people, concentrated primarily in southeastern Europe, while Mediterranean countries have seen a decline in cases.
View Article and Find Full Text PDF
Article Synopsis
  • Neurocysticercosis (NCC) is a rare disease in Europe caused by a tapeworm that mostly affects people from Africa, Latin America, and Asia.
  • Many patients experience symptoms like seizures, headaches, and other neurological issues, often related to travel to these regions.
  • Most patients were treated successfully, but it’s important for doctors in Europe to understand NCC better for better patient care.
View Article and Find Full Text PDF